Transcriptional expression profiles of oral squamous cell carcinomas

Cancer

Volumn 95, Issue 7, 2002, Pages 1482-1494

  Méndez, Eduardo ^a   Cheng, Chun ^b   Farwell, D Gregory ^a   Ricks, Sherianne ^b   Agoff, S Nicholas ^c   Futran, Neal D ^a   Weymuller Jr , Ernest A ^a   Maronian, Nicole C ^a   Zhao, Lue Ping ^b,d   Chen, Chu ^b,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Gene expression; Hierarchical clustering; Microarrays; Oral carcinoma

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CELL HETEROGENEITY; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUTH CANCER; OROPHARYNX CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOUTH NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS;

EID: 0036786327     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10875     Document Type: Article

References (52)

1. Kleinman DV, Crossett LS, Reis LAG, et al. Cancer of the oral cavity and pharynx: a statistics review monograph 1973-1987. Washington, DC: Department of Health and Human Services, Center for Disease Control, 1991.
2. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin. 1994;44:7-26.
3. Ishwad CS, Ferrell RE, Rossie KN, et al. Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancer. Int J Cancer. 1996;69:1-4.
4. Califano J, van d Westra W, Nawroz H, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996;56:2488-2492.
5. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA. 1994;91:9871-9875.
6. Roz L, Wu CL, Porter S, et al. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res. 1996;56:1228-1231.
7. Emilion G, Langdon JD, Speight P, Partridge M. Frequent gene deletions in potentially malignant oral lesions. Br J Cancer. 1996;73:809-813.
8. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res. 1996;56:2484-2487.
9. Mao L, Lee JS, Fan YH, et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med. 1996;2:682-685.
10. Rowley H, Jones AS, Field JK. Chromosome 18: a possible site for a tumour suppressor gene deletion in squamous cell carcinoma of the head and neck. Clin Otolaryngol. 1995;20:266-271.
11. Shah SI, Yip L, Greenberg B, et al. Two distinct regions of loss on chromosome arm 4q in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2000;126:1073-1076.
12. Oh Y, Mao L. Biomarkers in head and neck carcinoma [review] [109 references]. Curr Opin Oncol. 1997;9:247-225.
13. Xia W, Lau YK, Zhang HZ, et al. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res. 1997;3:3-9.
14. Wodicka L, Dong HL, Mittmann M, Ho MH, Lockhart DJ. Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat Biotechnol. 1997;15:1359-1367.
15. Thomas JG, Olson JM, Tapscott SJ, Zhao LP. An efficient and robust statistical modeling approach to analyze genomewide expression profiles: discovery of differentially expressed genes in human cancers. Genome Res. 2001;11:1227-1236.
16. Liang KY. Estimating effects of probands' characteristics on familial risk. I. Adjustment for censoring and correlated ages at onset. Genet Epidemiol. 1991;8:329-338.
17. Godambe VP. An optimum property of regular maximum likelihood estimation. Ann Math Stat. 1960;31:1208-1212.
18. Hsu JC. Multiple comparisons: theory and methods. London: Chapman & Hall, 1996.
19. Hochberg Y. A sharper Bonferroni procedure for multiple test of significance. Biometrika. 1988;75:800-802.
20. Alevizos I, Mahadevappa M, Zhang X, et al. Oral cancer in vivo gene expression profiling assisted by laser-capture microdissection and microarray analysis. Oncogene. 2001;20:6196-6204.
21. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer. 1953;6:963-968.
22. Ezura Y, Chakravarti S, Oldberg A, Chervoneva I, Birk DE. Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J Cell Biol. 2000;151:779-787.
23. Razzzaque MS, Taguchi T. The possible role of colligin/ HSP47, a collagen-binding protein, in the pathogenesis of human and experimental fibrotic diseases. Histol Histopathol. 1999;14:1199-1212.
24. Jones PL, Jones FS. Tenascin-C in development and disease: gene regulation and cell function [review]. Matrix Biol. 2000;19:581-596.
25. Dandachi N, Hauser-Kronberger C, More E, et al. Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins. J Pathol. 2001;193:181-189.
26. Gassmann MG, Werner S. Caveolin-1 and -2 expression is differentially regulated in cultured keratinocytes and within the regenerating epidermis of cutaneous wounds. Exp Cell Res. 2000;258:23-32.
27. Maekawa M, Ishizaki T, Boku S, et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 1999;285:895-898.
28. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA. 1998;95:6355-6360.
29. Fujisawa N, Hayashi S, Kurdowska A, Carr FK, Miller EJ. Inhibition of GRO alpha-induced human endothelial cell proliferation by the alpha-chemokine inhibitor antileukinate. Cytokine. 1999;11:231-238.
30. Owen JD, Strieter R, Burdick M, et al. Enhanced tumorforming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. Int J Cancer. 1997;73:94-103.
31. Semenza GL. Regulation of mammalian 02 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 1999;15:551-578.
32. Sharma B, Handler M, Eichstetter I, Whitelock JM, Nugent MA, Iozzo RV. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J Clin Invest. 1998;102:1599-1608.
33. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 1993;143:401-409.
34. Strieter RM, Polverini PJ, Arenberg DA, et al. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol. 1995;57:752-762.
35. Miller LJ, Kurtzman SH, Wang Y, Anderson KH, Lindquist RR, Kreutzer DL. Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res. 1998;18:77-81.
36. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992;258:1798-1801.
37. Vasile E, Tomita Y, Brown LF, Kocher O, Dvorak HF. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/ VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 2001;15:458-466.
38. Ogawa K, Pasqualini R, Lindberg RA, Kain R, Freeman AL, Pasquale EB. The ephrin-Al ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene. 2000;19:6043-6052.
39. Adams RH, Klein R. Eph receptors and ephrin ligands: essential mediators of vascular development. Trends Cardiovasc Med. 2000;10:183-188.
40. Nesselroth SM, Willis AI, Fuse S, et al. The C-terminal domain of thrombospondin-1 induces vascular smooth muscle cell chemotaxis. J Vasc Surg. 2001;33:595-600.
41. Streit M, Riccardi L, Velasco P, et al. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci USA. 1999;96:14888-14893.
42. Singer JD, Gurian-West M, Clurman B, Roberts JM. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev. 1999;13:2375-2387.
43. Talks KL, Turley H, Gatter KC, et al. The expression and distribution of the hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol. 2000;157:411-421.
44. Zhong H, De M, Laughner E, et al. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Res. 1999;59:5830-5835.
45. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1 alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 2000;60:4693-4696.
46. Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL. Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer. 2000;88:2606-2618.
47. Aebersold DM, Burri P, Beer KT, et al. Expression of hypoxia-inducible factor-1 alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 2001;61:2911-2916.
48. Starzynska T, Wiechowska-Kozlowska A, Marlicz K, et al. 5T4 oncofetal antigen in gastric carcinoma and its clinical significance. Eur J Gastroenterol Hepatol. 1998;10:479-484.
49. Shriver SP, Shriver MD, Tirpak DL, et al. Trinucleotide repeat length variation in the human ribosomal protein L14 gene (RPL14): localization to 3p21.3 and loss of heterozygosity in lung and oral cancers. Mutat Res. 1998;406:9-23.
50. Cannizzaro LA, Madaule P, Hecht F, Axel R, Croce CM, Huebner K. Chromosome localization of human ARH genes, a ras-related gene family. Genomics. 1990;6:197-203.
51. Ohyama H, Zhang X, Kohno Y, et al. Laser capture microdissection-generated target sample for high-density oligo-nucleotide array hybridization. Biotechniques. 2000;29:530-536.
52. Belbin TJ, Singh B, Barber I, et al. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res. 2002;62:1184-1190.